Skip to main content

and
  1. No Access

    Chapter

    Advances in Alternate, Non-PAP, Non-surgical Therapies in the Treatment of Obstructive Sleep Apnea

    Positive pressure therapy (PAP) is widely recognized as the gold standard treatment for OSA. Long-term adherence to PAP therapy, on the other hand, is typically low, ranging from 40 to 60%. Lifestyle modificat...

    Mahadevappa Hunasikatti, Seithikurippu R. Pandi-Perumal in Sleep Apnea Frontiers (2023)

  2. No Access

    Chapter

    Central Sleep Apnea: Advances in the Last Decade

    Central sleep apnea (CSA) is characterized by recurrent apneic episodes with absent respiratory effort. This is not a common clinical condition like obstructive sleep apnea. Central sleep apnea is diagnosed wh...

    Ahmed S. BaHammam, Mahadevappa Hunasikatti in Sleep Apnea Frontiers (2023)

  3. No Access

    Chapter

    Wearable Technologies/Consumer Sleep Technologies in Relation to Sleep Disorders Developments in the Last Decade

    Wearable devices [consumer sleep technologies (CSTs)] have disrupted sleep disorders management in the world today. In the USA, sleep disorders are managed in sleep disorders centers, usually accredited by AAS...

    Ahmed S. BaHammam, Seithikurippu R. Pandi-Perumal in Sleep Apnea Frontiers (2023)

  4. No Access

    Chapter

    Melatonin as a Chronobiotic and Cytoprotector in Healthy Aging

    A circadian alteration, as shown by a disturbed sleep and a low-degree inflammation, i.e., “inflammaging,” are two common disruptions oftenly seen in aging. Their aggravation contributes substantially to the e...

    Daniel P. Cardinali in Sleep and Clocks in Aging and Longevity (2023)

  5. No Access

    Chapter

    Current Clinical Perspective of Adult Obstructive Sleep Apnea: Symptomatology, Clinical Features, and Different Phenotypes

    The incidence and prevalence of obstructive sleep apnea (OSA) continue to rise in the United States and the world. The prevalence of OSA is conservatively estimated to be 3% among women and 10% among men 30 to...

    Ahmed S. BaHammam, Mahadevappa Hunasikatti in Sleep Apnea Frontiers (2023)

  6. No Access

    Chapter

    Traffic Safety in Sleep Deprivation, Sleepiness, and Sleep Disorders

    Every year, a substantial number of people are killed or injured due to motor vehicle accidents (MVAs). A large number of these collisions are caused by driving errors. Vehicles travel at fast speeds, necessit...

    Ahmed S. BaHammam, Mahadevappa Hunasikatti in Sleep Apnea Frontiers (2023)

  7. No Access

    Chapter

    Pineal Gland Physiology and Aging-Related Alterations in the Circadian Timing System

    For the last few decades, multiple research groups have studied the various processes, mechanisms, and regulations that can be manipulated to slow down the aging process in both animals and humans. Melatonin, ...

    Vijay K. Bharti, Seithikurippu R. Pandi-Perumal in Sleep and Clocks in Aging and Longevity (2023)

  8. No Access

    Chapter

    Impact of REM Sleep on Sleep Disorders: Current Perspectives

    Sleep is a complex process characterized by different stages, including rapid eye movement (REM) and non-rapid eye movement (NREM) sleep. Throughout the night, the body cycles through these stages, with REM sl...

    Ahmed S. BaHammam, Mahadevappa Hunasikatti in Sleep Apnea Frontiers (2023)

  9. No Access

    Chapter

    The Effects of Melanin-Concentrating Hormone on Neurotransmitter Systems Involved in the Generation and Maintenance of Wakefulness

    Within the central nervous system (CNS), melanin-concentrating hormone (MCH) participates in a number of functions including sleep-wake behavior. In this respect, MCHergic neurons project widely throughout the...

    Jaime M. Monti, Seithikurippu R. Pandi-Perumal in Melanin-Concentrating Hormone and Sleep (2018)

  10. No Access

    Chapter

    The Involvement of 5-HT2A Receptor in the Regulation of Sleep and Wakefulness, and the Potential Therapeutic Use of Selective 5-HT2A Receptor Antagonists and Inverse Agonists for the Treatment of an Insomnia Disorder

    Several agents have been shown to improve sleep induction and/or maintenance in patients with primary or comorbid insomnia. These include benzodiazepine and non-benzodiazepine receptor allosteric modulators, m...

    Jaime M. Monti M.D. in 5-HT2A Receptors in the Central Nervous Sy… (2018)

  11. No Access

    Chapter

    Sodium Oxybate (Xyrem®): A New and Effective Treatment for Narcolepsy with Cataplexy

    Sodium oxybate (SXB; Xyrem®) is the sodium salt of gamma hydroxybutyric acid (GHB). SXB has been approved in the United States for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients wit...

    Ahmed S. BaHammam, David Nelson Neubauer in Drug Treatment of Sleep Disorders (2015)

  12. No Access

    Chapter

    Circadian control by serotonin and melatonin receptors: Clinical relevance

    This chapter reviews the role of the different serotonin receptors located in the circadian apparatus and their possible clinical implications for the activity of antidepressants. The central oscillator locate...

    Daniel P. Cardinali in Serotonin and Sleep: Molecular, Functional… (2008)

  13. No Access

    Chapter

    Circadian Organization of the Immune Response

    Organisms populating the Earth are under the steady influence of daily and seasonal changes resulting from the planet's rotation and orbit around the sun. This periodic pattern is most prominently manifested b...

    Daniel P. Cardinali, Ana I. Esquifino, Georges J.M. Maestroni in Neuroimmunology of Sleep (2007)